![Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication](/docs/US/2024-10-29/US12129255B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
-
申请号： US17268107申请日： 2020-06-17
-
公开(公告)号： US12129255B2公开(公告)日： 2024-10-29
- 发明人: Eric P. Gillis , Christiana Iwuagwu
- 申请人： VIIV HEALTHCARE UK (No. 5) LIMITED
- 申请人地址： GB Middlesex
- 专利权人： ViiV Healthcare UK (No. 5) Limited
- 当前专利权人： ViiV Healthcare UK (No. 5) Limited
- 当前专利权人地址： GB Stevenage
- 代理商 Nora L. Stein
- 国际申请： PCT/IB2020/055653 2020.06.17
- 国际公布： WO2020/254985A 2020.12.24
- 进入国家日期： 2021-02-12
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K9/00 ; A61K45/06 ; A61P31/18
![Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication](/abs-image/US/2024/10/29/US12129255B2/abs.jpg.150x150.jpg)
摘要：
The compound
and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
公开/授权文献
信息查询
